FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2088049287> ?p ?o ?g. }

• W2088049287 abstract "It is estimated that 29% of deaths in Australia are caused by malignant disease each year and can be expected to increase with population ageing. In advanced cancer, the prevalence of fatigue is high at 70–90%, and can be related to the disease and/or the treatment. The negative impact of fatigue on function (physical, mental, social and spiritual) and quality of life is substantial for many palliative patients as well as their families/carers. This paper describes the design of single patient trials (n-of-1 s or SPTs) of a psychostimulant, methylphenidate hydrochloride (MPH) (5 mg bd), compared to placebo as a treatment for fatigue, with a population estimate of the benefit by the aggregation of multiple SPTs. Forty patients who have advanced cancer will be enrolled through specialist palliative care services in Australia. Patients will complete up to 3 cycles of treatment. Each cycle is 6 days long and has 3 days treatment and 3 days placebo. The order of treatment and placebo is randomly allocated for each cycle. The primary outcome is a reduction in fatigue severity as measured by the Functional Assessment of Cancer Therapy-fatigue subscale (FACIT-F). Secondary outcomes include adverse events, quality of life, additional fatigue assessments, depression and Australian Karnovsky Performance Scale. This study will provide high-level evidence using a novel methodological approach about the effectiveness of psychostimulants for cancer-related fatigue. If effective, the findings will guide clinical practice in reducing this prevalent condition to improve function and quality of life. Australian New Zealand Clinical Trials Registry ACTRN12609000794202" @default.
• W2088049287 created "2016-06-24" @default.
• W2088049287 creator A5000291278 @default.
• W2088049287 creator A5007993808 @default.
• W2088049287 creator A5008148365 @default.
• W2088049287 creator A5018621549 @default.
• W2088049287 creator A5026903516 @default.
• W2088049287 creator A5064514171 @default.
• W2088049287 creator A5065438948 @default.
• W2088049287 creator A5067631144 @default.
• W2088049287 creator A5069828492 @default.
• W2088049287 creator A5084042135 @default.
• W2088049287 creator A5090390097 @default.
• W2088049287 date "2013-04-23" @default.
• W2088049287 modified "2023-10-01" @default.
• W2088049287 title "Using aggregated single patient (N-of-1) trials to determine the effectiveness of psychostimulants to reduce fatigue in advanced cancer patients: a rationale and protocol" @default.
• W2088049287 cites W1963699948 @default.
• W2088049287 cites W1971867342 @default.
• W2088049287 cites W1990377465 @default.
• W2088049287 cites W2006994284 @default.
• W2088049287 cites W2013178875 @default.
• W2088049287 cites W2017578928 @default.
• W2088049287 cites W2023686483 @default.
• W2088049287 cites W2042225280 @default.
• W2088049287 cites W2047609053 @default.
• W2088049287 cites W2047647981 @default.
• W2088049287 cites W2050976571 @default.
• W2088049287 cites W2056410714 @default.
• W2088049287 cites W2092341812 @default.
• W2088049287 cites W2119399910 @default.
• W2088049287 cites W2120321114 @default.
• W2088049287 cites W2124669317 @default.
• W2088049287 cites W2143447257 @default.
• W2088049287 cites W2150471053 @default.
• W2088049287 cites W2155877563 @default.
• W2088049287 cites W2162333871 @default.
• W2088049287 cites W2163352737 @default.
• W2088049287 cites W2234954315 @default.
• W2088049287 doi "https://doi.org/10.1186/1472-684x-12-17" @default.
• W2088049287 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3651310" @default.
• W2088049287 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23617794" @default.
• W2088049287 hasPublicationYear "2013" @default.
• W2088049287 type Work @default.
• W2088049287 sameAs 2088049287 @default.
• W2088049287 citedByCount "20" @default.
• W2088049287 countsByYear W20880492872015 @default.
• W2088049287 countsByYear W20880492872016 @default.
• W2088049287 countsByYear W20880492872018 @default.
• W2088049287 countsByYear W20880492872020 @default.
• W2088049287 countsByYear W20880492872021 @default.
• W2088049287 countsByYear W20880492872022 @default.
• W2088049287 countsByYear W20880492872023 @default.
• W2088049287 crossrefType "journal-article" @default.
• W2088049287 hasAuthorship W2088049287A5000291278 @default.
• W2088049287 hasAuthorship W2088049287A5007993808 @default.
• W2088049287 hasAuthorship W2088049287A5008148365 @default.
• W2088049287 hasAuthorship W2088049287A5018621549 @default.
• W2088049287 hasAuthorship W2088049287A5026903516 @default.
• W2088049287 hasAuthorship W2088049287A5064514171 @default.
• W2088049287 hasAuthorship W2088049287A5065438948 @default.
• W2088049287 hasAuthorship W2088049287A5067631144 @default.
• W2088049287 hasAuthorship W2088049287A5069828492 @default.
• W2088049287 hasAuthorship W2088049287A5084042135 @default.
• W2088049287 hasAuthorship W2088049287A5090390097 @default.
• W2088049287 hasBestOaLocation W20880492871 @default.
• W2088049287 hasConcept C121608353 @default.
• W2088049287 hasConcept C126322002 @default.
• W2088049287 hasConcept C139719470 @default.
• W2088049287 hasConcept C142724271 @default.
• W2088049287 hasConcept C159110408 @default.
• W2088049287 hasConcept C162324750 @default.
• W2088049287 hasConcept C1862650 @default.
• W2088049287 hasConcept C197934379 @default.
• W2088049287 hasConcept C204787440 @default.
• W2088049287 hasConcept C27081682 @default.
• W2088049287 hasConcept C2776867660 @default.
• W2088049287 hasConcept C2778141389 @default.
• W2088049287 hasConcept C2779134260 @default.
• W2088049287 hasConcept C2779951463 @default.
• W2088049287 hasConcept C2908647359 @default.
• W2088049287 hasConcept C2994186709 @default.
• W2088049287 hasConcept C535046627 @default.
• W2088049287 hasConcept C71924100 @default.
• W2088049287 hasConcept C99454951 @default.
• W2088049287 hasConceptScore W2088049287C121608353 @default.
• W2088049287 hasConceptScore W2088049287C126322002 @default.
• W2088049287 hasConceptScore W2088049287C139719470 @default.
• W2088049287 hasConceptScore W2088049287C142724271 @default.
• W2088049287 hasConceptScore W2088049287C159110408 @default.
• W2088049287 hasConceptScore W2088049287C162324750 @default.
• W2088049287 hasConceptScore W2088049287C1862650 @default.
• W2088049287 hasConceptScore W2088049287C197934379 @default.
• W2088049287 hasConceptScore W2088049287C204787440 @default.
• W2088049287 hasConceptScore W2088049287C27081682 @default.
• W2088049287 hasConceptScore W2088049287C2776867660 @default.
• W2088049287 hasConceptScore W2088049287C2778141389 @default.
• W2088049287 hasConceptScore W2088049287C2779134260 @default.
• W2088049287 hasConceptScore W2088049287C2779951463 @default.
• W2088049287 hasConceptScore W2088049287C2908647359 @default.
• W2088049287 hasConceptScore W2088049287C2994186709 @default.

• next